To our knowledge, however, this is the first evidence of altered TLN1 and CEP55 in both cellular and non-cellular bone marrow compartments of patients with low- and high-risk MDS and with normal vs. abnormal karyotypes. This evidence concerns the gene CEP55 and myelodysplastic syndrome.